BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36213002)

  • 1. Pathway-based approach reveals differential sensitivity to E2F1 inhibition in glioblastoma.
    Alvarado AG; Tessema K; Muthukrishnan SD; Sober M; Kawaguchi R; Laks DR; Bhaduri A; Swarup V; Nathanson DA; Geschwind DH; Goldman SA; Kornblum HI
    Cancer Res Commun; 2022 Sep; 2(9):1049-1060. PubMed ID: 36213002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Proliferative Effects of E2F1 Suppression in Glioblastoma Cells.
    Godoy PRDV; Donaires FS; Montaldi APL; Sakamoto-Hojo ET
    Cytogenet Genome Res; 2021; 161(6-7):372-381. PubMed ID: 34482308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large-scale assessment of the gliomasphere model system.
    Laks DR; Crisman TJ; Shih MY; Mottahedeh J; Gao F; Sperry J; Garrett MC; Yong WH; Cloughesy TF; Liau LM; Lai A; Coppola G; Kornblum HI
    Neuro Oncol; 2016 Oct; 18(10):1367-78. PubMed ID: 27116978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-10b inhibition reduces E2F1-mediated transcription and miR-15/16 activity in glioblastoma.
    Teplyuk NM; Uhlmann EJ; Wong AH; Karmali P; Basu M; Gabriely G; Jain A; Wang Y; Chiocca EA; Stephens R; Marcusson E; Yi M; Krichevsky AM
    Oncotarget; 2015 Feb; 6(6):3770-83. PubMed ID: 25738367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protein kinase LKB1 promotes self-renewal and blocks invasiveness in glioblastoma.
    Caja L; Dadras MS; Mezheyeuski A; Rodrigues-Junior DM; Liu S; Webb AT; Gomez-Puerto MC; Ten Dijke P; Heldin CH; Moustakas A
    J Cell Physiol; 2022 Jan; 237(1):743-762. PubMed ID: 34350982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance.
    Zhou J; Tong F; Zhao J; Cui X; Wang Y; Wang G; Kang C; Liu X; Wang Q
    Cancer Biol Med; 2023 Jun; 20(5):385-400. PubMed ID: 37283490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells.
    Galanti G; Fisher T; Kventsel I; Shoham J; Gallily R; Mechoulam R; Lavie G; Amariglio N; Rechavi G; Toren A
    Acta Oncol; 2008; 47(6):1062-70. PubMed ID: 17934890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F1 identified by promoter and biochemical analysis as a central target of glioblastoma cell-cycle arrest in response to Ras inhibition.
    Blum R; Nakdimon I; Goldberg L; Elkon R; Shamir R; Rechavi G; Kloog Y
    Int J Cancer; 2006 Aug; 119(3):527-38. PubMed ID: 16496386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-485-5p inhibits glioblastoma progression by suppressing E2F transcription factor 1 under cisplatin treatment.
    Huang C; Ma L; Duan F; Li R; Zhang Y; Wang Y; Luo M; He Z; Luo Z
    Bioengineered; 2021 Dec; 12(1):8020-8030. PubMed ID: 34726120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stemness Is Enhanced in Gastric Cancer by a SET/PP2A/E2F1 Axis.
    Enjoji S; Yabe R; Tsuji S; Yoshimura K; Kawasaki H; Sakurai M; Sakai Y; Takenouchi H; Yoshino S; Hazama S; Nagano H; Oshima H; Oshima M; Vitek MP; Matsuura T; Hippo Y; Usui T; Ohama T; Sato K
    Mol Cancer Res; 2018 Mar; 16(3):554-563. PubMed ID: 29330298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription Factor E2F1 Enhances Hepatocellular Carcinoma Cell Proliferation and Stemness by Activating GINS1.
    Ren X; Shen L; Gao S
    J Environ Pathol Toxicol Oncol; 2024; 43(1):79-90. PubMed ID: 37824372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-testis specific gene OIP5: a downstream gene of E2F1 that promotes tumorigenesis and metastasis in glioblastoma by stabilizing E2F1 signaling.
    He J; Zhao Y; Zhao E; Wang X; Dong Z; Chen Y; Yang L; Cui H
    Neuro Oncol; 2018 Aug; 20(9):1173-1184. PubMed ID: 29547938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXO1 inhibits prostate cancer cell proliferation via suppressing E2F1 activated NPRL2 expression.
    Tang Y; Jiang L; Zhao X; Hu D; Zhao G; Luo S; Du X; Tang W
    Cell Biol Int; 2021 Dec; 45(12):2510-2520. PubMed ID: 34459063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription factor p53-mediated activation of miR-519d-3p and downregulation of E2F1 attenuates prostate cancer growth and metastasis.
    Zhang D; Yang XJ; Luo QD; Xue L; Chong T
    Cancer Gene Ther; 2022 Jul; 29(7):1001-1011. PubMed ID: 34799723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2F and STAT3 provide transcriptional synergy for histone variant H2AZ activation to sustain glioblastoma chromatin accessibility and tumorigenicity.
    Yoon J; Grinchuk OV; Tirado-Magallanes R; Ngian ZK; Tay EXY; Chuah YH; Lee BWL; Feng J; Crasta KC; Ong CT; Benoukraf T; Ong DST
    Cell Death Differ; 2022 Jul; 29(7):1379-1394. PubMed ID: 35058574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.
    Alonso MM; Fueyo J; Shay JW; Aldape KD; Jiang H; Lee OH; Johnson DG; Xu J; Kondo Y; Kanzawa T; Kyo S; Bekele BN; Zhou X; Nigro J; McDonald JM; Yung WK; Gomez-Manzano C
    J Natl Cancer Inst; 2005 Nov; 97(21):1589-600. PubMed ID: 16264179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-Interacting Protein 140 Enhanced Temozolomide-Induced Cellular Apoptosis Through Regulation of E2F1 in Human Glioma Cell Lines.
    Tsai HC; Wei KC; Chen PY; Huang CY; Chen KT; Lin YJ; Cheng HW; Huang CH; Wang HT
    Neuromolecular Med; 2022 Jun; 24(2):113-124. PubMed ID: 34075570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme.
    Qiu S; Huang D; Yin D; Li F; Li X; Kung HF; Peng Y
    Biochim Biophys Acta; 2013 Oct; 1832(10):1697-707. PubMed ID: 23707559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E2F transcription factors associated with up-regulated genes in glioblastoma.
    Donaires FS; Godoy PR; Leandro GS; Puthier D; Sakamoto-Hojo ET
    Cancer Biomark; 2017; 18(2):199-208. PubMed ID: 27983535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A functional SNP in the MDM2 promoter mediates E2F1 affinity to modulate cyclin D1 expression in tumor cell proliferation.
    Yang ZH; Zhou CL; Zhu H; Li JH; He CD
    Asian Pac J Cancer Prev; 2014; 15(8):3817-23. PubMed ID: 24870800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.